Related Experiment Video
Updated: Jan 29, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Subclinical Atrial Fibrillation, Embolic Risk, and Anticoagulant Treatment
1Honorary Member of the Romanian Academy Professor, "Carol Davila" University of Medicine and Pharmacy, Senior consultant, Emergency University Hospital, Bucharest, Romania.
This review addresses the critical clinical judgment of treating silent atrial fibrillation, focusing on decisions regarding anticoagulation for device-detected cases. It highlights the importance of this condition in internal medicine practice.
Area of Science:
- Internal Medicine
- Cardiology
Background:
- Editorial review by Professor Leonida Gherasim, a distinguished member of the Romanian Academy.
- Focuses on the clinical challenge of managing silent atrial fibrillation, often detected incidentally by medical devices.
Discussion:
- The core issue is the decision-making process for anticoagulation in patients with silent atrial fibrillation.
- Emphasizes the significant clinical judgment required for appropriate treatment strategies.
Key Insights:
- Silent atrial fibrillation presents a unique diagnostic and therapeutic challenge.
- Accurate assessment is crucial for preventing thromboembolic events.
Outlook:
- Further research and consensus are needed for optimal management protocols.
- This review contributes to the ongoing discourse in cardiovascular internal medicine.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism I: Introduction
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Relative Risk

